How long is the conservative window?

Three to six months of structured conservative treatment is the evidence-based answer — and two separate NHS pathway documents make that explicit. Both the Devon Formulary and HWE Clinical Guidance formally codify 4–6 months of non-surgical management as the standard pre-referral window for hip osteoarthritis, with twelve weeks representing the earliest point at which secondary-care referral becomes appropriate.

Within that window, the expected components are well defined: a structured muscle-strengthening physiotherapy programme, weight management support, NSAIDs or analgesics for symptom control, activity modification away from high-impact loading, and corticosteroid injections for acute inflammatory flares. The Devon pathway adds a harder requirement on top of the calendar threshold — a physiotherapy course completed within the preceding twelve months is mandatory before an arthroplasty referral can be made.

This is not an administrative holding pattern. Natural-history data from the Devon pathway document shows that 25% of hip pain presentations resolve within three months and 35% within twelve months; only 15% of patients show radiographic progression within three years, and 28% within six years. The majority of people who engage genuinely with conservative care will either stabilise or improve without ever needing surgery. Recognising that trajectory is what allows clinicians to distinguish the patient for whom more time is genuinely useful from the one whose window is quietly closing — which is the question the rest of this article addresses.

What conservative management should actually include

Not all conservative care is equal, and that distinction matters: the window's validity depends on how it was used, not just how long it lasted.

A genuine structured programme rests on four active components:

• Hip-specific physiotherapy — targeted loading exercises to strengthen the hip abductors, external rotators, and core stabilisers, combined with gait retraining and movement pattern correction. Advice alone, a single leaflet of home exercises, or sporadic attendance at a community gym class does not meet this threshold.
• Weight management — treated as an active clinical target, not an optional lifestyle note. Reducing load through the hip joint during the phase when cartilage is still resilient is a mechanical intervention in its own right.
• NSAIDs or analgesics alongside activity modification — pain control is not passive. Adequate analgesia allows patients to engage fully with exercise and reduces impingement-provoked loading during daily movement.
• Corticosteroid injections for acute flares — these sit comfortably within a structured conservative trial. Their use signals a responsive management plan, not a treatment failure. Receiving an injection does not reset or shorten the clock; the window continues.

What does not constitute a genuine conservative trial is a 'rest and see' approach: months of reduced activity with no structured physiotherapy, intermittent GP appointments for repeat prescriptions, and no formal assessment of loading capacity or gait. Patients who have followed this path may feel they have 'already tried conservative treatment' — but they haven't completed a genuine trial, and neither their clinician nor a specialist can meaningfully evaluate the window's outcome on that basis.

Why many patients stabilise without escalating

The statistics from S1 are not simply reassuring numbers — they reflect something real about hip OA's biological character. The condition is not a single, uniform disease marching predictably towards replacement; it is a spectrum of presentations with genuinely variable trajectories, and most of the population sits towards the stable end of that spectrum.

What makes individual trajectory hard to predict is itself instructive. A 2019 systematic review in Arthritis Research & Therapy found that only a small number of factors were strongly associated with radiographic progression: age, joint space width at presentation, and the degree of femoral head migration. Symptom severity alone, pain intensity, and functional limitation — the things most apparent in the consulting room — are not reliable predictors of structural deterioration. That limitation cuts both ways: it argues against early escalation based on symptoms that may settle, and it makes a supervised conservative trial the only practical way to distinguish the patient who stabilises from the one who does not.

For presentations without an identifiable structural driver — no radiological FAI morphology, no dysplasia — this ambiguity is most pronounced. In that group, a well-executed conservative programme functions as both treatment and diagnostic test. Sustained improvement confirms the patient belongs to the stabilising majority; failure to improve, or gradual functional decline, is the signal that warrants looking more carefully at structural factors.

Signals the window is closing

Calendar time matters less than what the hip is doing. Certain patterns — functional rather than radiological — are the clearest signal that specialist assessment should not wait for the six-month mark to arrive.

Night pain that breaks sleep is the most consistent of these. Pain that wakes a person at 2 a.m., or makes it impossible to find a comfortable position, is joint-level inflammation that has moved beyond what targeted exercise can currently suppress. It warrants earlier review.

A shrinking comfortable walking distance is equally telling, particularly when the patient can track a slow, progressive decline over weeks or months. The key word is progressive: if someone notices they are now planning their route around benches, or that they turn back earlier than they did six months ago, structural change is the more likely explanation than an undertreated soft-tissue problem.

Pain that does not settle with rest points in the same direction. Hip pain that lingers long after the provoking activity stops — persisting into the evening after a morning walk — suggests active synovitis rather than simple loading-related discomfort.

Progressive stiffness limiting daily tasks is worth tracking explicitly: difficulty putting on socks and shoes, pain getting in and out of a car, hesitation on stairs, morning stiffness that takes longer to ease each week. These are functional milestones with a direction of travel.

The subjective tipping point where bad days reliably outnumber good days is not a soft complaint — it is a clinically meaningful shift in the balance of the condition. Orthopaedic practice regards this pattern as a genuine referral trigger.

Mechanical symptoms — catching, a sensation of locking, or the joint giving way — should prompt assessment sooner than the standard conservative window would otherwise suggest. These features raise the possibility of structural derangement, such as labral pathology or acetabular delamination, that conservative measures cannot address and that progressive load will worsen.

The science behind these signals is most clearly established in FAI-related early hip OA. In a prospective cohort of 760 hips, those with symptoms lasting three years or more showed advanced acetabular cartilage damage in 51% of cases, compared with 34% in those symptomatic for under three years (p = 0.002), with inferior outcomes across every patient-reported domain. The first one-to-three years of symptoms appears to be the decisive preservation opportunity. The evidence for precise progression thresholds in non-structural early hip OA — absent identifiable FAI morphology — is less clearly defined, but the functional signals described above remain the practical guide to escalation regardless of structural subtype.

Imaging and structural findings that prompt earlier referral

Imaging does two distinct jobs here: it characterises the structural subtype driving symptoms, and it signals how urgently the preservation window needs to be acted on.

Plain X-ray: alpha angle and KL grade

On a standard AP pelvis or Dunn-view film, the alpha angle measures the asphericity of the femoral head. A EULAR 2023 meta-analysis of 10 studies and 447 FAI patients found that alpha angle predicts chondral health with good-to-excellent effect sizes; an alpha angle of 65° or above carries substantially increased risk of significant cartilage damage. This provides a plain-film threshold that can indicate a need to move beyond open-ended conservative management.

Kellgren-Lawrence (KL) grading on the same film marks the outer boundary of the conservative window. At KL Grade III or IV, loading the joint harder through aggressive physiotherapy can do more harm than good — accelerating cartilage shearing, subchondral bone stress, and synovitis. Conservative care at this stage shifts towards symptom management rather than structural preservation.

MRI: detecting cartilage change before collapse

T1rho MRI detects proteoglycan depletion in cartilage — change that precedes visible joint space loss on X-ray. Anterior lateral cartilage T1rho values have been shown to correlate strongly with six-month patient-reported outcomes after surgery (r = −0.45 to −0.64), making cartilage quality on MRI an objective referral signal even when symptoms remain moderate. MRI also provides the most reliable non-invasive detection of acetabular cartilage delamination, a progressive FAI complication that conservative measures cannot reverse.

The biological dimension

RNA sequencing of hip cartilage tissue adds molecular context. Early FAI cartilage carries upregulated anabolic signals — FGF18 and WNT16 — consistent with active repair capacity. As OA progresses, these give way to catabolic dominance: MMP13 and ADAMTS4. The preservation window has a biological correlate, not only a clinical one.

One important caveat applies throughout: the alpha angle threshold and T1rho data are currently best supported in FAI-related and dysplastic presentations, where most surgical cohort data originate. Evidence for equivalent structural thresholds in non-FAI early hip OA is less precisely defined. Across all subtypes, imaging findings should be interpreted alongside symptoms and clinical examination — a structural finding in isolation is rarely sufficient justification for escalation.

What a cartilage preservation consultation actually involves

Requesting a specialist hip assessment is not a commitment to treatment — it is a structured review of where the hip currently sits on the preservation timeline. A consultation works through symptom trajectory, functional status, and any imaging already to hand, building a clinical picture of which options remain viable and at what level of urgency.

For patients who have completed a genuine conservative programme without sufficient improvement, there is a recognised stage between continued self-management and surgical reconstruction. Biologic and injection approaches occupy this middle ground, aimed at supporting the joint's residual repair capacity before structural damage progresses further.

One option at this tier is ChondroFiller injection — an injectable collagen scaffold placed under ultrasound guidance as an outpatient procedure. In patients with focal cartilage involvement, the scaffold provides a matrix for the patient's own progenitor cells to initiate new tissue formation. It belongs to a distinct category from joint replacement, arthroscopic procedures, and physiotherapy-led management, and is positioned on the pathway after conservative care has been genuinely exhausted.

The decision whether to use this approach — or any other — depends on structural findings, symptom burden, and whether the biological window for cartilage preservation remains open. Establishing that is precisely what the assessment is for.

Specialist hip assessment in London

The London Cartilage Clinic on Harley Street provides specialist hip cartilage evaluation. Professor Paul Y. F. Lee leads the UK ChondroFiller injection service there. Liquid Cartilage™ is delivered in the UK at the London Cartilage Clinic on Harley Street; assessment appointments are available via londoncartilage.com.

1. [1] EP82 Pre-surgical hip cartilage evaluation using MRI T1rho mapping on periacetabular osteotomy (PAO) outcomes. (2025). https://doi.org/10.1093/jhps/hnaf069.216 https://doi.org/10.1093/jhps/hnaf069.216
2. [2] AB1396 Future of Hip Cartilage Preservation: α Angle Endpoints Optimise Indications for Conservative Care — EULAR 2023. (2023). https://doi.org/10.1136/annrheumdis-2023-eular.90 https://doi.org/10.1136/annrheumdis-2023-eular.90
3. [3] EP6.35 Longer Symptom Duration in Patients with FAI is Associated with Increased Acetabular Cartilage Damage and Inferior Patient-Reported Outcomes. (2025). https://doi.org/10.1093/jhps/hnaf011.324 https://doi.org/10.1093/jhps/hnaf011.324
4. [4] An Updated Review on the Diagnosis and Treatment of Acetabular Cartilage Delamination in Patients with FAI. (2025). https://doi.org/10.1177/23259671251389194 https://doi.org/10.1177/23259671251389194
5. [5] Whole-genome RNA sequencing identifies distinct transcriptomic profiles in impingement cartilage between FAI and hip OA. (2022). https://doi.org/10.1002/jor.25485 https://doi.org/10.1002/jor.25485